{"id":"W2329699817","doi":"10.1097/mpg.0000000000001149","title":"Time for Personalized Biologic Therapy","year":2016,"lang":"en","type":"letter","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Infliximab; Ulcerative colitis; Inflammatory bowel disease; Dosing; Disease; Crohn's disease; Internal medicine; Vedolizumab; Adalimumab; Clinical trial; Drug; Immunology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007060001,0.0002825224,0.000791951,0.0003411116,0.00009947085,0.00001159291,0.0002255384,0.001480372,0.0004535426],"category_scores_gemma":[0.00009733938,0.0001721214,0.0004320625,0.00005196272,0.0004080103,0.00006273091,0.00003156263,0.001016033,0.00001707586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002857498,"about_ca_system_score_gemma":0.00003303462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":2.889066e-7,"about_ca_topic_score_gemma":9.552104e-8,"domain_scores_codex":[0.9980307,0.0005720891,0.0006125122,0.0002685815,0.00004801234,0.0004681134],"domain_scores_gemma":[0.9982498,0.0005932408,0.000769411,0.0001133458,0.0002433332,0.00003090217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003035601,0.0001113103,0.0009462811,0.00009173335,0.0003628125,0.00003366054,0.000009841657,4.458769e-9,0.004384721,0.000006939413,0.9896621,0.00135507],"study_design_scores_gemma":[0.007649675,0.00711113,0.0003118257,0.00004952305,0.0004993204,0.0008321771,0.000007348625,3.680163e-7,0.0002875531,0.001275613,0.9818226,0.0001529253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.05118945,0.03475995,0.002144376,0.907773,0.002692699,0.0007632276,0.0006166871,0.00003074179,0.00002986335],"genre_scores_gemma":[0.004243025,0.08589602,0.006441969,0.8514057,0.04236568,0.0001282407,0.000484726,0.0001193694,0.008915207],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05636723,"threshold_uncertainty_score":0.9998159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02254318816610979,"score_gpt":0.2691309600622989,"score_spread":0.2465877718961891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}